Cargando…
Understanding Ovarian Cancer: iTRAQ-Based Proteomics for Biomarker Discovery
Despite many years of studies, ovarian cancer remains one of the top ten cancers worldwide. Its high mortality rate is mainly due to lack of sufficient diagnostic methods. For this reason, our research focused on the identification of blood markers whose appearance would precede the clinical manifes...
Autores principales: | Swiatly, Agata, Horala, Agnieszka, Matysiak, Jan, Hajduk, Joanna, Nowak-Markwitz, Ewa, Kokot, Zenon J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121953/ https://www.ncbi.nlm.nih.gov/pubmed/30065196 http://dx.doi.org/10.3390/ijms19082240 |
Ejemplares similares
-
MALDI-TOF-MS analysis in discovery and identification of serum proteomic patterns of ovarian cancer
por: Swiatly, Agata, et al.
Publicado: (2017) -
Diagnostic Value of Serum Angiogenesis Markers in Ovarian Cancer Using Multiplex Immunoassay
por: Horala, Agnieszka, et al.
Publicado: (2017) -
Usefulness of Amino Acid Profiling in Ovarian Cancer Screening with Special Emphasis on Their Role in Cancerogenesis
por: Plewa, Szymon, et al.
Publicado: (2017) -
Serum Free Amino Acid Profiling in Differential Diagnosis of Ovarian Tumors—A Comparative Study with Review of the Literature
por: Horala, Agnieszka, et al.
Publicado: (2021) -
MALDI-MSI—A Step Forward in Overcoming the Diagnostic Challenges in Ovarian Tumors
por: Pietkiewicz, Dagmara, et al.
Publicado: (2020)